Latest pharma news updates... Nov 02
Natera and BGI Genomics entered into a partnership to commercialize Natera’s Signatera test in China... Jun 28
MiNA will utilize its saRNA platform to research up to five targets selected by Lilly that aim to address diseases across Lilly's key therapeutic ... May 15
... Apr 02
... Mar 26
This collaboration aims to discover and develop novel KATP channel activators with the potential to treat rare diseases... Feb 24
This collaboration will improve the field of the animal healthcare industry... Feb 23
This collaboration can provide a variety of NGS detection solutions... Feb 22
Within the scope of this partnership, HALIX will provide manufacturing of clinical supply of NovalGen’s therapies... Feb 22
The inhibitor is for the potential treatment of Immunological and Neurodegenerative diseases... Feb 22
Compugen Ltd expands collaboration agreement with Bristol Myers Squibb with phase 1b combination study of COM701 with opdivo C... Feb 22
EMERCell signs strategic partnership with Onward Therapeutics for the development of its NK cell therapy technology ... Feb 18
Molecular Templates collaborates with Bristol Myers Squibb for the discovery and development of next generation engineered toxin bodies ... Feb 17
This move marks an expansion of the strategic partnership between Evonik and the vaccine manufacturer BioNTech... Feb 13
The McQuade Center for Strategic Research and Development and Eikonizo Therapeutics enter agreement to develop treatments for patients with are diseases ... Feb 10
Inceptua will have exclusive rights to distribute and commercialize Apealea in Europe... Dec 28
The collaboration will help keep the manufacturing costs down and ensure long-term flexibility to meet future demand for years to come... Dec 23
The licensing agreement will be effective in 33 countries throughout the European region including France, Italy, and Spain... Dec 23
GSK licenses global rights to a portfolio of GPR35 agonists designed by Sosei Heptares using its StaR technology and structure-based drug design platform... Dec 22
The agreement that gives Astrea the ability to secure exclusive access to the Affimer technology for applications in bioprocessing... Dec 22
The ability to create such vaccines could minimize or eliminate the cold chain requirements for global deployment and mass vaccination programmes with RNA-based vaccines ... Dec 19
The vaccine was co-invented by the University of Oxford and its spin-out company Vaccitech... Dec 12
This collaboration will help Crescendo’s proprietary transgenic platform and engineering expertise are being used to build Humabody-based therapeutics against certain targets selected by ... Dec 11
This collaboration will help both companies to work together to test and further optimize PeptiDream’s Growth Hormone Receptor Antagonist“GHRA†peptide candidates... Dec 09
Through collaboration companies will leverage Pfizer's extensive data and experience with PostEra's technological resources to promote the science of generative chemistry... Dec 08
-Advertisements-
Saturday, April 20, 2024
